Current status and challenges in HER2 IHC assessment: scoring survey results in Japan

20246 citationsJournal Articlehybrid Open Access

Authors

Takashi Sakatani · Nippon Medical School Hospital

Hitoshi Tsuda · National Defense Medical College

Masayuki Yoshida · Tokyo National Hospital

Naoko Honma · Toho University

Shinobu Masuda · Nihon University

Tomo Osako · Japanese Foundation For Cancer Research

Amiko Hayashi ·

Abstract

This study highlighted the current status of HER2 expression scoring by IHC for breast cancer among pathologists in Japan. These findings underscore the challenges in HER2 IHC scoring cases and emphasize the need for improved standardization and training, especially in the evolving landscape of HER2-targeted therapies.

Topics & Keywords

HER2/EGFR in Cancer Research Monoclonal and Polyclonal Antibodies Research Chronic Lymphocytic Leukemia Research

Publication Details

Published in: Breast Cancer Research and Treatment

Volume 210, Issue 1, pp. 27-36

DOI: 10.1007/s10549-024-07532-2

Field-Weighted Citation Impact: 1.68

Command Palette

Current status and challenges in HER2 IHC assessment: scoring survey results in Japan

Authors

Abstract

Topics & Keywords

Publication Details